cefotaxime has been researched along with Aortic-Aneurysm* in 2 studies
1 review(s) available for cefotaxime and Aortic-Aneurysm
Article | Year |
---|---|
Abdominal aortic aneurysm infected with Campylobacter fetus subspecies fetus.
We report a survivor of Campylobacter fetus septicemia from an infected abdominal aortic aneurysm who was successfully treated with an anatomic graft reconstruction and antibiotics. According to a survey of the English-language medical literature this was the fourth such patient successfully treated. C. fetus sepsis associated with an abdominal aortic aneurysm was first reported in 1971. The first patient to survive reconstruction of an aortic tube graft aneurysm infected with C. fetus was reported in 1983. Because the natural history of an aneurysm infected by C. fetus appears to be rapid progression to rupture, patients should be operated on promptly. All patients reported in the literature who were operated on before rupture survived. Survival was independent of the type of reconstruction. When the aneurysm ruptured all patients died. Whereas extraanatomic bypass is generally considered the procedure of choice for an infected abdominal aneurysm, the aneurysms of our patient and three other patients cited in the literature were reconstructed with anatomically placed prosthetic grafts. In the absence of other contraindications such as a grossly evident purulent infection, an abdominal aortic aneurysm infected by C. fetus may represent a subset of infected aneurysms that can be treated successfully with an anatomically placed prosthetic graft and antibiotics. Topics: Amoxicillin; Aneurysm, Infected; Aorta, Abdominal; Aortic Aneurysm; Blood Vessel Prosthesis; Campylobacter fetus; Campylobacter Infections; Cefotaxime; Gentamicins; Humans; Male; Middle Aged; Polyethylene Terephthalates | 1989 |
1 other study(ies) available for cefotaxime and Aortic-Aneurysm
Article | Year |
---|---|
Salmonella infections of the abdominal aorta cured with prolonged antibiotic treatment.
Three cases of endovascular infection of atherosclerotic aneurysm of the abdominal aorta due to Salmonella spp. are described. 'Breakthrough' or relapsing bacteraemia were major clues for diagnosis in each case. They were treated with a prolonged course of bactericidal antibiotics before surgery. Resection with an interposed graft was performed in all cases and antibiotic treatment continued. Two of our patients have survived for more than two years and the other for 18 months without evidence of relapse. Thus, it would appear possible at times to treat successfully mycotic aneurysm of the abdominal aorta with antimicrobial agents plus resection of the aneurysm followed by in situ bypass grafting. Extra-anatomical grafts should be kept for infections due to antimicrobial-resistant organisms or when periaortic infection is widespread. Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm; Cefotaxime; Combined Modality Therapy; Gentamicins; Humans; Male; Middle Aged; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 1987 |